News
The U.S. Food and Drug Administration will meet its targets for completing reviews of new drugs despite mass firings at the ...
Multiple current and laid-off FDA employees said the abrupt layoffs had resulted in delays and disruptions to the agency's ...
The U.S. Food and Drug Administration has delayed its decision on marketing approval for Stealth BioTherapeutics' treatment ...
The head of the Food and Drug Administration said Tuesday that the agency is now looking at whether it will still approve COVID-19 vaccines for next winter, citing a lack of data on booster shots.
The FDA doesn’t plan to execute a reorganization of the agency but will consolidate offices that handle travel, technology, ...
FDA vaccine oversight is shifting, with increased scrutiny and mixed messaging sparking concerns among health experts.
Recently, the FDA announced the removal of certain compounded GLP1 ingredients from its drug shortage list. These ingredients ...
Novavax said Monday that the Food and Drug Administration was asking the company to run a new clinical trial of its vaccine.
Stealth BioTherapeutics had expected the FDA to respond on Tuesday to its marketing application for elamipretide to treat ...
The rolls were sold at the retail level in Pennsylvania, California, Connecticut, Maryland, Delaware, and Ohio, according to ...
A batch of the drug is under a limited voluntary recall after a shipping error exposed certain doses to improper temperatures.
7don MSN
The US Food and Drug Administration plans to phase out the use of petroleum-based synthetic dyes in the US food supply due to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results